Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

Link Between Antibiotics and Biofilms

Researchers from USC and the Oak Crest Institute of Science have discovered the link between antibiotics and bacterial biofilm formation leading to ...read more

Anthrax Incident Points to Safety Issues

The Centers for Disease Control and Prevention (CDC) released a report today that reviews the early June incident that involved the ...read more

Tetanus Infection

The CDC offers information on tetanus infection caused by Clostridium tetani. ...read more

Healthcare Reform

Infection prevention's role in quality improvement initiatives is becoming more of an imperative within the overall efforts by healthcare ...read more

Latest Headlines

Kimberly-Clark Professional Offers Web-Based Guides for Health and Hygiene

ROSWELL, Ga. -- Kimberly-Clark Professional introduces Workplace Wellness Guides, a series of web-based guides relating to health and hygiene issues in away-from-home settings. The guides are available for downloading and printing at ...More
November 12, 2004 Posted in News, Environmental Hygiene, Hand Hygiene
Meeting the Challenge of Influenza

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) is responding to the current public health issue regarding influenza with the introduction of "Get Clued to the Flu," a public awareness campaign that emphasizes the continuum of care during the flu season. The ...More
November 11, 2004 Posted in News
PEGASYS(R) Receives New Indication in Europe Allowing Hepatitis C Patients with “Normal” Liver Enzyme Levels to be Treated

BASEL, Switzerland -- Roche announced that the European Medicines Agency (EMEA) has approved PEGASYS(R) for the treatment of hepatitis C patients with persistently “normal” liver enzymes. This extension of the current label is based on the results of a pioneering study(i) ...More
November 11, 2004 Posted in News
Nanogen Announces Clinical Diagnostic to Simultaneously Detect Multiple Respiratory Viruses

SAN DIEGO -- Nanogen, Inc., announced that it is developing new analyte specific reagents (ASRs) for clinical reference laboratories to develop and validate a single test to detect six of the most common respiratory viruses. Instead of testing for multiple viruses using ...More
November 11, 2004 Posted in News
Domestic Ducks Could Pose New Avian Influenza Threat

WASHINGTON and ROME -- Domestic ducks may be acting as a silent reservoir for the H5N1 Avian Influenza virus, which is highly pathogenic for chickens, and may thus have acquired an important new role in the transmission of the virus to other poultry and, possibly, to humans ...More
November 11, 2004 Posted in News
AHF Commends Sheriff's Department for Successful HIV Prevention and Testing Project in LA County Jails

LOS ANGELES -- AIDS Healthcare Foundation (AHF), the largest AIDS treatment provider in the United States, commends the Los Angeles County Sheriff's Department as a recipient of the Los Angeles County's 18th Annual Quality and Productivity Awards for its successful HIV ...More
November 11, 2004 Posted in News
U.S. Department of Homeland Security Sponsored Evaluation Confirms Superior Performance of Response Biomedical's RAMP(R) Anthrax Test

VANCOUVER -- Response Biomedical Corp. announced the company's RAMP(R) Anthrax Test is the only rapid biological detection system to meet the new performance standards introduced by AOAC INTERNATIONAL for rapid immunoassay-based anthrax detection systems. Following rigorous ...More
November 11, 2004 Posted in News
Pharmasset Initiates Racivir(R) Phase II HIV Study

ATLANTA -- Pharmasset, Inc. has initiated a Phase II clinical study to assess the safety, tolerability, and antiviral effect of substituting Racivir (RCV) for Epivir(R) (lamivudine, 3TC) in treatment-experienced HIV-infected individuals. The goal of this study, RCV-201, is ...More
November 11, 2004 Posted in News
Insights from Global Panel on the Emerging Crisis in Infectious Disease

Recently, The Pfizer Journal(R) convened a panel of international experts to discuss the emerging crisis in infectious disease. The panel consisted of key thought leaders from all aspects of the infectious disease, including researchers, physicians, economists, technology ...More
November 11, 2004 Posted in News
New Study Demonstrates the Clinical and Economic Challenges of Staphylococcus Aureus Infections

ROCKVILLE, Md. -- Nabi Biopharmaceuticals announced results from a study presented at the 2004 annual meeting of the American Heart Association that showed that Staphylococcus aureus bacteremia (Staphylococcus aureus bloodstream infections) in patients with cardiovascular ...More
November 11, 2004 Posted in News